Corcept Therapeutics
RANK
13
Company Information
As of 10/29/20
Country
U.S.
Headquarters
Menlo Park, Calif.
Industry
Pharmaceuticals
CEO
Joseph Belanoff
Website
Company Type
Public
Ticker
CORT
Revenues ($M)
$335
Profits ($M)
$106
Market Value ($M)
$2,028
Employees
206
Revenue and net income for the four quarters ended on or before April 30,2020. Market value as of Sept. 29, 2020
Fastest-Growing CompaniesAs of 10/29/20
Revenue 3 Yr Growth Rank
5
Revenue 3 Yr Annual Growth Rate
53%
EPS 3 Yr Growth Rank
20
EPS 3 Yr Annual Growth Rate
80%
Total Return 3 Yr Rank
56
Total Return 3 Yr Annual Rate (Through June 30, 2020)
13%
Beat S&P 500 3 Yr Return (10.7%)
yes
Current Streak
2
Years on List
2
Sector
Health Care
Historical Data
| Year | Revenues ($M) | Profits ($M) |
|---|---|---|
| 2019 | $25874% | $76 |
Lists ranking Corcept Therapeutics